Listed

Karyopharm Therapeutics Inc.

KPTINasdaqCIK 1503802HealthcareFiscal year ends Dec 31

Share

Share this page

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$33.4m, Q2 FY2026
Operating income−$22.5m, Q2 FY2026
Net income−$67.0m, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m36.0Revenue, Q3 FY2023, three months to 2023-09-30$36.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2024-11-05, accession 0000950170-24-121076.Report this figure33.7Revenue, Q4 FY2023, three months to 2023-12-31$33.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-13, accession 0001193125-26-049397. Derived: 12-month figure less the 9-month figure.Report this figure33.1Revenue, Q1 FY2024, three months to 2024-03-31$33.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-12, accession 0000950170-25-069231.Report this figure42.8Revenue, Q2 FY2024, three months to 2024-06-30$42.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-08-11, accession 0000950170-25-106238.Report this figure38.8Revenue, Q3 FY2024, three months to 2024-09-30$38.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-03, accession 0001193125-25-261667.Report this figure30.5Revenue, Q4 FY2024, three months to 2024-12-31$30.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-13, accession 0001193125-26-049397. Derived: 12-month figure less the 9-month figure.Report this figure30.0Revenue, Q1 FY2025, three months to 2025-03-31$30.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-14, accession 0001193125-26-222827.Report this figure37.9Revenue, Q2 FY2025, three months to 2025-06-30$37.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-13, accession 0001193125-26-347906.Report this figure44.0Revenue, Q3 FY2025, three months to 2025-09-30$44.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-03, accession 0001193125-25-261667.Report this figure34.1Revenue, Q4 FY2025, three months to 2025-12-31$34.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-13, accession 0001193125-26-049397. Derived: 12-month figure less the 9-month figure.Report this figure35.1Revenue, Q1 FY2026, three months to 2026-03-31$35.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-14, accession 0001193125-26-222827.Report this figure33.4Revenue, Q2 FY2026, three months to 2026-06-30$33.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-13, accession 0001193125-26-347906.Report this figure
Cost of revenue$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Research and development$m35.6Research and development, Q3 FY2023, three months to 2023-09-30$35.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-05, accession 0000950170-24-121076.Report this figure39.4Research and development, Q4 FY2023, three months to 2023-12-31$39.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-13, accession 0001193125-26-049397. Derived: 12-month figure less the 9-month figure.Report this figure35.4Research and development, Q1 FY2024, three months to 2024-03-31$35.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-12, accession 0000950170-25-069231.Report this figure38.4Research and development, Q2 FY2024, three months to 2024-06-30$38.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-11, accession 0000950170-25-106238.Report this figure36.1Research and development, Q3 FY2024, three months to 2024-09-30$36.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-03, accession 0001193125-25-261667.Report this figure33.3Research and development, Q4 FY2024, three months to 2024-12-31$33.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-13, accession 0001193125-26-049397. Derived: 12-month figure less the 9-month figure.Report this figure34.6Research and development, Q1 FY2025, three months to 2025-03-31$34.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-14, accession 0001193125-26-222827.Report this figure32.8Research and development, Q2 FY2025, three months to 2025-06-30$32.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-13, accession 0001193125-26-347906.Report this figure30.5Research and development, Q3 FY2025, three months to 2025-09-30$30.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-03, accession 0001193125-25-261667.Report this figure27.7Research and development, Q4 FY2025, three months to 2025-12-31$27.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-13, accession 0001193125-26-049397. Derived: 12-month figure less the 9-month figure.Report this figure33.8Research and development, Q1 FY2026, three months to 2026-03-31$33.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-14, accession 0001193125-26-222827.Report this figure29.0Research and development, Q2 FY2026, three months to 2026-06-30$29.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-13, accession 0001193125-26-347906.Report this figure
Selling, general and administrative$m30.8Selling, general and administrative, Q3 FY2023, three months to 2023-09-30$30.8m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2024-11-05, accession 0000950170-24-121076.Report this figure30.7Selling, general and administrative, Q4 FY2023, three months to 2023-12-31$30.7m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-13, accession 0001193125-26-049397. Derived: 12-month figure less the 9-month figure.Report this figure29.5Selling, general and administrative, Q1 FY2024, three months to 2024-03-31$29.5m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-05-12, accession 0000950170-25-069231.Report this figure31.1Selling, general and administrative, Q2 FY2024, three months to 2024-06-30$31.1m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-08-11, accession 0000950170-25-106238.Report this figure27.6Selling, general and administrative, Q3 FY2024, three months to 2024-09-30$27.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-03, accession 0001193125-25-261667.Report this figure27.2Selling, general and administrative, Q4 FY2024, three months to 2024-12-31$27.2m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-13, accession 0001193125-26-049397. Derived: 12-month figure less the 9-month figure.Report this figure27.4Selling, general and administrative, Q1 FY2025, three months to 2025-03-31$27.4m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-14, accession 0001193125-26-222827.Report this figure28.5Selling, general and administrative, Q2 FY2025, three months to 2025-06-30$28.5m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-13, accession 0001193125-26-347906.Report this figure26.6Selling, general and administrative, Q3 FY2025, three months to 2025-09-30$26.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-03, accession 0001193125-25-261667.Report this figure22.8Selling, general and administrative, Q4 FY2025, three months to 2025-12-31$22.8m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-13, accession 0001193125-26-049397. Derived: 12-month figure less the 9-month figure.Report this figure26.7Selling, general and administrative, Q1 FY2026, three months to 2026-03-31$26.7m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-14, accession 0001193125-26-222827.Report this figure25.9Selling, general and administrative, Q2 FY2026, three months to 2026-06-30$25.9m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-13, accession 0001193125-26-347906.Report this figure
Operating income$m(31.3)Operating income, Q3 FY2023, three months to 2023-09-30−$31.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-05, accession 0000950170-24-121076.Report this figure(37.8)Operating income, Q4 FY2023, three months to 2023-12-31−$37.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-13, accession 0001193125-26-049397. Derived: 12-month figure less the 9-month figure.Report this figure(33.8)Operating income, Q1 FY2024, three months to 2024-03-31−$33.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-12, accession 0000950170-25-069231.Report this figure(28.1)Operating income, Q2 FY2024, three months to 2024-06-30−$28.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-11, accession 0000950170-25-106238.Report this figure(26.3)Operating income, Q3 FY2024, three months to 2024-09-30−$26.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-03, accession 0001193125-25-261667.Report this figure(31.3)Operating income, Q4 FY2024, three months to 2024-12-31−$31.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-13, accession 0001193125-26-049397. Derived: 12-month figure less the 9-month figure.Report this figure(33.3)Operating income, Q1 FY2025, three months to 2025-03-31−$33.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-14, accession 0001193125-26-222827.Report this figure(24.4)Operating income, Q2 FY2025, three months to 2025-06-30−$24.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-13, accession 0001193125-26-347906.Report this figure(15.2)Operating income, Q3 FY2025, three months to 2025-09-30−$15.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-03, accession 0001193125-25-261667.Report this figure(17.8)Operating income, Q4 FY2025, three months to 2025-12-31−$17.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-13, accession 0001193125-26-049397. Derived: 12-month figure less the 9-month figure.Report this figure(26.8)Operating income, Q1 FY2026, three months to 2026-03-31−$26.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-14, accession 0001193125-26-222827.Report this figure(22.5)Operating income, Q2 FY2026, three months to 2026-06-30−$22.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-13, accession 0001193125-26-347906.Report this figure
Interest expense$m6.1Interest expense, Q3 FY2023, three months to 2023-09-30$6.1m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2023-11-02, accession 0000950170-23-057754.Report this figure6.2Interest expense, Q4 FY2023, three months to 2023-12-31$6.2m. XBRL concept us-gaap:InterestExpense. 10-K filed 2024-02-29, accession 0000950170-24-022650. Derived: 12-month figure less the 9-month figure.Report this figure5.9Interest expense, Q1 FY2024, three months to 2024-03-31$5.9m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-05-08, accession 0000950170-24-055672.Report this figure8.9Interest expense, Q2 FY2024, three months to 2024-06-30$8.9m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-08-06, accession 0000950170-24-091210.Report this figure11.4Interest expense, Q3 FY2024, three months to 2024-09-30$11.4m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-03, accession 0001193125-25-261667.Report this figure11.2Interest expense, Q4 FY2024, three months to 2024-12-31$11.2m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-02-13, accession 0001193125-26-049397. Derived: 12-month figure less the 9-month figure.Report this figure11.0Interest expense, Q1 FY2025, three months to 2025-03-31$11.0m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-14, accession 0001193125-26-222827.Report this figure11.2Interest expense, Q2 FY2025, three months to 2025-06-30$11.2m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-13, accession 0001193125-26-347906.Report this figure11.0Interest expense, Q3 FY2025, three months to 2025-09-30$11.0m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-03, accession 0001193125-25-261667.Report this figure12.6Interest expense, Q4 FY2025, three months to 2025-12-31$12.6m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-02-13, accession 0001193125-26-049397. Derived: 12-month figure less the 9-month figure.Report this figure12.6Interest expense, Q1 FY2026, three months to 2026-03-31$12.6m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-14, accession 0001193125-26-222827.Report this figure13.1Interest expense, Q2 FY2026, three months to 2026-06-30$13.1m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-13, accession 0001193125-26-347906.Report this figure
Income tax$m0.0Income tax, Q3 FY2023, three months to 2023-09-30$12.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-05, accession 0000950170-24-121076.Report this figure0.1Income tax, Q4 FY2023, three months to 2023-12-31$130.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-13, accession 0001193125-26-049397. Derived: 12-month figure less the 9-month figure.Report this figure0.1Income tax, Q1 FY2024, three months to 2024-03-31$71.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-12, accession 0000950170-25-069231.Report this figure0.1Income tax, Q2 FY2024, three months to 2024-06-30$67.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-11, accession 0000950170-25-106238.Report this figure0.0Income tax, Q3 FY2024, three months to 2024-09-30$28.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-03, accession 0001193125-25-261667.Report this figure(0.1)Income tax, Q4 FY2024, three months to 2024-12-31−$109.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-13, accession 0001193125-26-049397. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2025, three months to 2025-03-31$36.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-14, accession 0001193125-26-222827.Report this figure0.0Income tax, Q2 FY2025, three months to 2025-06-30$40.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-13, accession 0001193125-26-347906.Report this figure0.0Income tax, Q3 FY2025, three months to 2025-09-30$34.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-03, accession 0001193125-25-261667.Report this figure(0.1)Income tax, Q4 FY2025, three months to 2025-12-31−$67.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-13, accession 0001193125-26-049397. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2026, three months to 2026-03-31$1.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-14, accession 0001193125-26-222827.Report this figure0.0Income tax, Q2 FY2026, three months to 2026-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-13, accession 0001193125-26-347906.Report this figure
Net income$m(34.5)Net income, Q3 FY2023, three months to 2023-09-30−$34.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-05, accession 0000950170-24-121076.Report this figure(41.8)Net income, Q4 FY2023, three months to 2023-12-31−$41.8m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-13, accession 0001193125-26-049397. Derived: 12-month figure less the 9-month figure.Report this figure(37.4)Net income, Q1 FY2024, three months to 2024-03-31−$37.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-05-12, accession 0000950170-25-069231.Report this figure23.8Net income, Q2 FY2024, three months to 2024-06-30$23.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-08-11, accession 0000950170-25-106238.Report this figure(32.1)Net income, Q3 FY2024, three months to 2024-09-30−$32.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-03, accession 0001193125-25-261667.Report this figure(30.8)Net income, Q4 FY2024, three months to 2024-12-31−$30.8m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-13, accession 0001193125-26-049397. Derived: 12-month figure less the 9-month figure.Report this figure(23.5)Net income, Q1 FY2025, three months to 2025-03-31−$23.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-14, accession 0001193125-26-222827.Report this figure(37.3)Net income, Q2 FY2025, three months to 2025-06-30−$37.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001193125-26-347906.Report this figure(33.1)Net income, Q3 FY2025, three months to 2025-09-30−$33.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-03, accession 0001193125-25-261667.Report this figure(102)Net income, Q4 FY2025, three months to 2025-12-31−$102.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-13, accession 0001193125-26-049397. Derived: 12-month figure less the 9-month figure.Report this figure(22.4)Net income, Q1 FY2026, three months to 2026-03-31−$22.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-14, accession 0001193125-26-222827.Report this figure(67.0)Net income, Q2 FY2026, three months to 2026-06-30−$67.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001193125-26-347906.Report this figure
Diluted EPS$ per share(0.30)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.30 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-05, accession 0000950170-24-121076.Report this figurenot reported(4.85)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$4.85 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-12, accession 0000950170-25-069231.Report this figure(2.97)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$2.97 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-11, accession 0000950170-25-106238.Report this figure(3.85)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$3.85 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-03, accession 0001193125-25-261667.Report this figurenot reported(2.77)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$2.77 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-14, accession 0001193125-26-222827.Report this figure(4.32)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$4.32 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-13, accession 0001193125-26-347906.Report this figure(3.82)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$3.82 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-03, accession 0001193125-25-261667.Report this figurenot reported(1.24)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$1.24 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-14, accession 0001193125-26-222827.Report this figure(2.32)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$2.32 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-13, accession 0001193125-26-347906.Report this figure
Basic EPS$ per share(0.30)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.30 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-05, accession 0000950170-24-121076.Report this figurenot reported(4.85)Basic EPS, Q1 FY2024, three months to 2024-03-31−$4.85 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-12, accession 0000950170-25-069231.Report this figure2.26Basic EPS, Q2 FY2024, three months to 2024-06-30$2.26 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-11, accession 0000950170-25-106238.Report this figure(3.85)Basic EPS, Q3 FY2024, three months to 2024-09-30−$3.85 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-03, accession 0001193125-25-261667.Report this figurenot reported(2.77)Basic EPS, Q1 FY2025, three months to 2025-03-31−$2.77 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-14, accession 0001193125-26-222827.Report this figure(4.32)Basic EPS, Q2 FY2025, three months to 2025-06-30−$4.32 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-13, accession 0001193125-26-347906.Report this figure(3.82)Basic EPS, Q3 FY2025, three months to 2025-09-30−$3.82 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-03, accession 0001193125-25-261667.Report this figurenot reported(1.02)Basic EPS, Q1 FY2026, three months to 2026-03-31−$1.02 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-14, accession 0001193125-26-222827.Report this figure(2.32)Basic EPS, Q2 FY2026, three months to 2026-06-30−$2.32 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-13, accession 0001193125-26-347906.Report this figure

Balance sheet

Cash and equivalents$55.0m, Q2 FY2026
Shareholders' equity−$330.2m, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m43.7Cash and equivalents, Q3 FY2023, at 2023-09-30$43.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-05, accession 0000950170-24-121076.Report this figure52.2Cash and equivalents, FY2023, at 2023-12-31$52.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-02-13, accession 0001193125-26-049397.Report this figure30.6Cash and equivalents, Q1 FY2024, at 2024-03-31$30.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-12, accession 0000950170-25-069231.Report this figure84.8Cash and equivalents, Q2 FY2024, at 2024-06-30$84.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-11, accession 0000950170-25-106238.Report this figure72.8Cash and equivalents, Q3 FY2024, at 2024-09-30$72.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-03, accession 0001193125-25-261667.Report this figure62.5Cash and equivalents, FY2024, at 2024-12-31$62.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-02-13, accession 0001193125-26-049397.Report this figure38.8Cash and equivalents, Q1 FY2025, at 2025-03-31$38.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-14, accession 0001193125-26-222827.Report this figure38.7Cash and equivalents, Q2 FY2025, at 2025-06-30$38.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-13, accession 0001193125-26-347906.Report this figure37.7Cash and equivalents, Q3 FY2025, at 2025-09-30$37.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-03, accession 0001193125-25-261667.Report this figure60.5Cash and equivalents, FY2025, at 2025-12-31$60.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-13, accession 0001193125-26-347906.Report this figure90.9Cash and equivalents, Q1 FY2026, at 2026-03-31$90.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-14, accession 0001193125-26-222827.Report this figure55.0Cash and equivalents, Q2 FY2026, at 2026-06-30$55.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-13, accession 0001193125-26-347906.Report this figure
Current assets$m263Current assets, Q3 FY2023, at 2023-09-30$263.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-02, accession 0000950170-23-057754.Report this figure234Current assets, FY2023, at 2023-12-31$233.9m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-02-19, accession 0000950170-25-022765.Report this figure198Current assets, Q1 FY2024, at 2024-03-31$198.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-08, accession 0000950170-24-055672.Report this figure209Current assets, Q2 FY2024, at 2024-06-30$208.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-06, accession 0000950170-24-091210.Report this figure185Current assets, Q3 FY2024, at 2024-09-30$184.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-05, accession 0000950170-24-121076.Report this figure156Current assets, FY2024, at 2024-12-31$156.5m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-02-13, accession 0001193125-26-049397.Report this figure120Current assets, Q1 FY2025, at 2025-03-31$120.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-12, accession 0000950170-25-069231.Report this figure97.9Current assets, Q2 FY2025, at 2025-06-30$97.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-11, accession 0000950170-25-106238.Report this figure89.7Current assets, Q3 FY2025, at 2025-09-30$89.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-03, accession 0001193125-25-261667.Report this figure103Current assets, FY2025, at 2025-12-31$103.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-13, accession 0001193125-26-347906.Report this figure126Current assets, Q1 FY2026, at 2026-03-31$126.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-14, accession 0001193125-26-222827.Report this figure106Current assets, Q2 FY2026, at 2026-06-30$106.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-13, accession 0001193125-26-347906.Report this figure
Total assets$m270Total assets, Q3 FY2023, at 2023-09-30$270.0m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-02, accession 0000950170-23-057754.Report this figure240Total assets, FY2023, at 2023-12-31$240.4m. XBRL concept us-gaap:Assets. 10-K filed 2025-02-19, accession 0000950170-25-022765.Report this figure204Total assets, Q1 FY2024, at 2024-03-31$204.5m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-08, accession 0000950170-24-055672.Report this figure214Total assets, Q2 FY2024, at 2024-06-30$214.0m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-06, accession 0000950170-24-091210.Report this figure189Total assets, Q3 FY2024, at 2024-09-30$189.5m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-05, accession 0000950170-24-121076.Report this figure164Total assets, FY2024, at 2024-12-31$164.4m. XBRL concept us-gaap:Assets. 10-K filed 2026-02-13, accession 0001193125-26-049397.Report this figure128Total assets, Q1 FY2025, at 2025-03-31$127.7m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-12, accession 0000950170-25-069231.Report this figure105Total assets, Q2 FY2025, at 2025-06-30$104.9m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-11, accession 0000950170-25-106238.Report this figure96.2Total assets, Q3 FY2025, at 2025-09-30$96.2m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-03, accession 0001193125-25-261667.Report this figure108Total assets, FY2025, at 2025-12-31$108.4m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-13, accession 0001193125-26-347906.Report this figure131Total assets, Q1 FY2026, at 2026-03-31$131.4m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-14, accession 0001193125-26-222827.Report this figure111Total assets, Q2 FY2026, at 2026-06-30$111.3m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-13, accession 0001193125-26-347906.Report this figure
Current liabilities$m62.1Current liabilities, Q3 FY2023, at 2023-09-30$62.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-02, accession 0000950170-23-057754.Report this figure69.5Current liabilities, FY2023, at 2023-12-31$69.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-02-19, accession 0000950170-25-022765.Report this figure65.3Current liabilities, Q1 FY2024, at 2024-03-31$65.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-08, accession 0000950170-24-055672.Report this figure57.6Current liabilities, Q2 FY2024, at 2024-06-30$57.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-06, accession 0000950170-24-091210.Report this figure61.5Current liabilities, Q3 FY2024, at 2024-09-30$61.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-05, accession 0000950170-24-121076.Report this figure92.3Current liabilities, FY2024, at 2024-12-31$92.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-02-13, accession 0001193125-26-049397.Report this figure90.4Current liabilities, Q1 FY2025, at 2025-03-31$90.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-12, accession 0000950170-25-069231.Report this figure99.2Current liabilities, Q2 FY2025, at 2025-06-30$99.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-11, accession 0000950170-25-106238.Report this figure87.2Current liabilities, Q3 FY2025, at 2025-09-30$87.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-03, accession 0001193125-25-261667.Report this figure92.1Current liabilities, FY2025, at 2025-12-31$92.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-13, accession 0001193125-26-347906.Report this figure117Current liabilities, Q1 FY2026, at 2026-03-31$117.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-14, accession 0001193125-26-222827.Report this figure134Current liabilities, Q2 FY2026, at 2026-06-30$134.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-13, accession 0001193125-26-347906.Report this figure
Total liabilities$m370Total liabilities, Q3 FY2023, at 2023-09-30$370.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-02, accession 0000950170-23-057754.Report this figure377Total liabilities, FY2023, at 2023-12-31$376.6m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-02-19, accession 0000950170-25-022765.Report this figure373Total liabilities, Q1 FY2024, at 2024-03-31$373.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-08, accession 0000950170-24-055672.Report this figure346Total liabilities, Q2 FY2024, at 2024-06-30$346.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-06, accession 0000950170-24-091210.Report this figure349Total liabilities, Q3 FY2024, at 2024-09-30$349.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-05, accession 0000950170-24-121076.Report this figure350Total liabilities, FY2024, at 2024-12-31$350.4m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-02-13, accession 0001193125-26-049397.Report this figure334Total liabilities, Q1 FY2025, at 2025-03-31$333.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-12, accession 0000950170-25-069231.Report this figure344Total liabilities, Q2 FY2025, at 2025-06-30$343.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-11, accession 0000950170-25-106238.Report this figure365Total liabilities, Q3 FY2025, at 2025-09-30$365.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-03, accession 0001193125-25-261667.Report this figure401Total liabilities, FY2025, at 2025-12-31$401.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-13, accession 0001193125-26-347906.Report this figure397Total liabilities, Q1 FY2026, at 2026-03-31$397.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-14, accession 0001193125-26-222827.Report this figure441Total liabilities, Q2 FY2026, at 2026-06-30$441.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-13, accession 0001193125-26-347906.Report this figure
Long-term debt$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Shareholders' equity$m(100)Shareholders' equity, Q3 FY2023, at 2023-09-30−$100.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-05, accession 0000950170-24-121076.Report this figure(136)Shareholders' equity, FY2023, at 2023-12-31−$136.2m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-02-13, accession 0001193125-26-049397.Report this figure(169)Shareholders' equity, Q1 FY2024, at 2024-03-31−$169.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-08-11, accession 0000950170-25-106238.Report this figure(132)Shareholders' equity, Q2 FY2024, at 2024-06-30−$132.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-03, accession 0001193125-25-261667.Report this figure(160)Shareholders' equity, Q3 FY2024, at 2024-09-30−$159.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-03, accession 0001193125-25-261667.Report this figure(186)Shareholders' equity, FY2024, at 2024-12-31−$186.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001193125-26-347906.Report this figure(206)Shareholders' equity, Q1 FY2025, at 2025-03-31−$205.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001193125-26-347906.Report this figure(239)Shareholders' equity, Q2 FY2025, at 2025-06-30−$238.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001193125-26-347906.Report this figure(269)Shareholders' equity, Q3 FY2025, at 2025-09-30−$269.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-03, accession 0001193125-25-261667.Report this figure(293)Shareholders' equity, FY2025, at 2025-12-31−$292.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001193125-26-347906.Report this figure(266)Shareholders' equity, Q1 FY2026, at 2026-03-31−$265.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001193125-26-347906.Report this figure(330)Shareholders' equity, Q2 FY2026, at 2026-06-30−$330.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001193125-26-347906.Report this figure

Cash flow

Operating cash flow−$24.9m, Q2 FY2026
Capital expenditure$0, Q4 FY2025
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(29.5)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$29.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-05, accession 0000950170-24-121076. Derived: 9-month figure less the 6-month figure.Report this figure(18.6)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$18.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-13, accession 0001193125-26-049397. Derived: 12-month figure less the 9-month figure.Report this figure(43.7)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$43.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-12, accession 0000950170-25-069231.Report this figure(38.5)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$38.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-11, accession 0000950170-25-106238. Derived: 6-month figure less the 3-month figure.Report this figure(19.5)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$19.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-03, accession 0001193125-25-261667. Derived: 9-month figure less the 6-month figure.Report this figure(25.8)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$25.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-13, accession 0001193125-26-049397. Derived: 12-month figure less the 9-month figure.Report this figure(39.0)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$39.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-14, accession 0001193125-26-222827.Report this figure(18.7)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$18.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-13, accession 0001193125-26-347906. Derived: 6-month figure less the 3-month figure.Report this figure(5.9)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$5.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-03, accession 0001193125-25-261667. Derived: 9-month figure less the 6-month figure.Report this figure(11.8)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$11.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-13, accession 0001193125-26-049397. Derived: 12-month figure less the 9-month figure.Report this figure(22.7)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$22.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-14, accession 0001193125-26-222827.Report this figure(24.9)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$24.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-13, accession 0001193125-26-347906. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m0.0Capital expenditure, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-05, accession 0000950170-24-121076. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-13, accession 0001193125-26-049397. Derived: 12-month figure less the 9-month figure.Report this figure0.2Capital expenditure, Q1 FY2024, three months to 2024-03-31$195.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-12, accession 0000950170-25-069231.Report this figure0.0Capital expenditure, Q2 FY2024, three months to 2024-06-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-11, accession 0000950170-25-106238. Derived: 6-month figure less the 3-month figure.Report this figure0.0Capital expenditure, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-03, accession 0001193125-25-261667. Derived: 9-month figure less the 6-month figure.Report this figure(0.1)Capital expenditure, Q4 FY2024, three months to 2024-12-31−$53.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-13, accession 0001193125-26-049397. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-12, accession 0000950170-25-069231.Report this figure0.0Capital expenditure, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-11, accession 0000950170-25-106238. Derived: 6-month figure less the 3-month figure.Report this figure0.0Capital expenditure, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-03, accession 0001193125-25-261667. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-13, accession 0001193125-26-049397. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reported

Shares

Diluted shares (weighted)28,938, Q2 FY2026
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares80.2Diluted shares (weighted), Q3 FY2022, three months to 2022-09-3080,210,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-02, accession 0000950170-23-057754.Report this figure113Diluted shares (weighted), Q1 FY2023, three months to 2023-03-31113,481,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-08, accession 0000950170-24-055672.Report this figure114Diluted shares (weighted), Q2 FY2023, three months to 2023-06-30114,207,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-06, accession 0000950170-24-091210.Report this figure0.1Diluted shares (weighted), Q3 FY2023, three months to 2023-09-30114,401 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-05, accession 0000950170-24-121076.Report this figure0.0Diluted shares (weighted), Q1 FY2024, three months to 2024-03-317,700 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-12, accession 0000950170-25-069231.Report this figure0.0Diluted shares (weighted), Q2 FY2024, three months to 2024-06-3010,295 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-11, accession 0000950170-25-106238.Report this figure0.0Diluted shares (weighted), Q3 FY2024, three months to 2024-09-308,336 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-03, accession 0001193125-25-261667.Report this figure0.0Diluted shares (weighted), Q1 FY2025, three months to 2025-03-318,470 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-14, accession 0001193125-26-222827.Report this figure0.0Diluted shares (weighted), Q2 FY2025, three months to 2025-06-308,620 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-13, accession 0001193125-26-347906.Report this figure0.0Diluted shares (weighted), Q3 FY2025, three months to 2025-09-308,669 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-03, accession 0001193125-25-261667.Report this figure0.0Diluted shares (weighted), Q1 FY2026, three months to 2026-03-3124,715 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-14, accession 0001193125-26-222827.Report this figure0.0Diluted shares (weighted), Q2 FY2026, three months to 2026-06-3028,938 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-13, accession 0001193125-26-347906.Report this figure

Shares outstanding: 22.68mShares outstanding, period not labelled, at 2026-08-0622,681,460 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-13, accession 0001193125-26-347906.Report this figure at Aug 6, 2026, from the cover of the 10-Q filed Aug 13, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:41 ET. Listed shows no prices and gives no investment advice.